| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
3e-08 |
| mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
2e-06 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
| mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
7e-06 |
| mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-06 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
4e-05 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |